Nse2 Antibody - BSA Free

Western Blot: Nse2 AntibodyBSA Free [NBP1-76263]

Western Blot: Nse2 Antibody - BSA Free [NBP1-76263] - Nse2 Antibody [NBP1-76263] - CRISPR-Cas9-mediated targeting of NSMCE2. Western blot analysis of the NSMCE2 protein in the final NSMCE2 null and WT cells. beta-Actin was used as a loading control. Image collected and cropped by CiteAb from the following publication (https://www.mdpi.com/1422-0067/17/11/1782) licensed under a CC-BY license.

Western Blot: Nse2 AntibodyBSA Free [NBP1-76263]

Western Blot: Nse2 Antibody - BSA Free [NBP1-76263] - Nse2 Antibody [NBP1-76263] - 293 cell lysate with Nse2 antibody at (A) 0.5 and (B) 1 ug/mL.

Western Blot: Nse2 Antibody - BSA Free [NBP1-76263] -

Western Blot: Nse2 Antibody - BSA Free [NBP1-76263] - CRISPR-Cas9-mediated targeting of NSMCE2: (A) Left panel, transfected U2OS cells (GFP+) under bright field & fluorescence; right panel, FACS enrichment of GFP+ cells. Bar = 50 µm; (B) Expected cleavage bands (approximately 304 & 113 bp, arrowheads) generated by Surveyor nuclease digestion. For negative control (−) transfection of the pX458 plasmids without NSMCE2 sgRNA was performed; (C) Sequencing analysis for characterization of the CRISPR-Cas9-induced frameshift mutations. Red letters represent the 20-nt targeting sequences, while blue letters refer to the protospacer-adjacent motif (PAM); (D) Western blot analysis of the NSMCE2 protein in the final NSMCE2 null & WT cells. beta-Actin was used as a loading control. Image collected & cropped by CiteAb from the following publication (http://www.mdpi.com/1422-0067/17/11/1782), licensed under a CC-BY license. Not internally tested by Novus Biologicals.